Fig. 3From: Complete response to orally administered melphalan in malignant pleural effusion from an occult female genital organ primary neoplasm with BRCA1/2 mutations: a case reportChange of serum tumor markers cancer antigen 15–3 (green) and cancer antigen 125 (red) along treatment course. Yellow box: The period of tamoxifen usage. Deep blue arrow: Each course of melphalan therapyBack to article page